Abstract Nasopharyngeal angiofi broma is a rare, highly vascular locally invasive tumor with a strong tendency to bleed. It usually occurs in young adolescent males. This is a retrospective study of 53 patients with nasopharyngeal angiofi broma. All the cases were treated surgically by different conventional approaches depending upon the extent of the mass. Transpalatal approach was used in 32 cases, lateral rhinotomy in 13 cases and a combination of transpalatine + lateral rhinotomy + caldwel-luc in 8 cases. There is no recurrence in 49 cases till date. However, recurrence was noted in four cases within six months. Three out of four patients with recurrence had to undergo repeat surgery for the removal of angiofi broma within six months while the remaining one was referred to radiotherapy as the mass was invading the cavernous sinus. The various clinical presentation and treatment modalities are discussed.
Introduction
Juvenile nasopharyngeal angiofi broma is a rare, histologically benign tumor found almost exclusively in adolescent males (peak 15 years) and therefore called juvenile nasopharyngeal angiofi broma. It is a highly vascular, aggressive and locally invasive tumor. This tumor has a high potential to cause severe epistaxis, extension to adjacent structures and intracranial extension. Hippocrates described the tumor in 5th century BC and Friedberg fi rst used the term angiofibroma in 1940 [1] . The tumor starts adjacent to sphenopalatine foramen. The large tumors are frequently bilobed or dumbbell shaped with one portion in the nasopharynx and the other extending to the pterygopalatine fossa. Nasopharyngeal angiofi broma accounts for 0.05% of all neoplasms of the head and neck with a relatively high incidence in India. Presenting symptoms and signs are determined by the location, size and extension of the tumor. Main symptoms are progressive nasal obstruction, epistaxis and rhinorrhoea. Extension of the tumor into surrounding areas can produce facial swelling (frog face deformity) and proptosis. Diagnosis is made mainly by clinical examination and imaging studies. Angiography helps to demarcate the blood supply of the tumor and identifi cation of the feeding vessel but its real utility is questionable. Surgical excision has been the main choice for treatment of nasopharyngeal angiofi broma. The present study focuses on the clinical presentation and the various conventional surgical approaches employed to deal with the tumor.
Materials and methods
The retrospective study was done in the Department of Otorhinolaryngology and Head & Neck Surgery, B. J. Medical College, Ahmedabad, India. A total of 53 patients who were admitted and operated by the fi rst author from 1996 to 2006 were included in this study. The youngest patient was 12 years of age and the oldest was of 19 years. The mean age of the patients in our study was 15.5 years. All the patients presented with recurrent bout of epistaxis and two patients presented with severe epistaxis and required packing at the time of admission. The remaining had intermittent bout of epistaxis and did not require packing at the time of admission. The other symptoms were nasal obstruction, change of voice, nasal discharge, headache, proptosis, ear ache, deafness and face deformity (Table 1 ). All the patients were subjected to conventional X-ray of paranasal sinus water's view, lateral view of skull and CT scan (Figs. 1a, b, c, d ). Nasal endoscopy was done in all the cases for evaluation and clinical diagnosis. The Fisch classifi cation of staging of tumor [1] was done. Stage I tumor limited to nasal cavity with no bony destruction; stage II tumor invading pterygomaxillary fossa and paranasal sinuses with bony destruction; stage III tumor invading infratemporal fossa, orbit and/or parasellar region remaining lateral to the cavernous sinus (Fig. 2) and stage IV tumor invading the cavernous sinus, optic chiasmal region and/or pituitary fossa. Txenty-six patients (49%) were in stage II (Table 2) where tumor was extending into maxillary antrum, ethmoid sinus and infratemporal fossa or cheek. None of the patient had orbital involvement. Twenty-two patients (41.5%) were in stage III in which tumor was extending into the infratemporal fossa. 
